Boardroom Media (CFO News)
At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Columbia based CFO’ operating in the Pharmaceutical space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Nizar Bharmal
Chief Financial Officer of Aurin Biotech
Nizar Bharmal is a renowned Certified General Accountant with over 30 years of well-merited accomplishments in his field. He was granted the professional designation of CGA in 1980. Early in his career he worked in the real estate development and investment field. From 1982 until 1985 Mr. Bharmal was Manager of the Bomarc Group, a management company providing services for reporting companies. In 1985, Mr. Bharmal passed the Canadian Securities Course with honors and founded Nizar Bharmal Inc. as a public practice dedicated to providing an array of accounting services, including Canadian and US taxation, financial consulting and corporate management for reporting companies. During his career, he has served as CEO and CFO for several publicly listed companies, where he has gained deep insight into both operations and regulatory affairs. Mr. Bharmal’s extensive association with and commitment to local business communities has resulted in admiration and confidence from many of his colleagues.
Follow Nizar Bharmal:
About ArcPacific Resources, Aurin Biotech: Aurin Biotech Inc. is a private company established to advance the development of a remarkable collection of small molecules.
Richard Lindahl
Executive Vice President & Chief Financial Officer of Emergent BioSolutions
Rich Lindahl currently serves as the executive vice president and chief financial officer at Emergent BioSolutions.
Follow Richard Lindahl:
About Corporate Executive Board (CEB), Emergent BioSolutions: Emergent BioSolutions develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats.
Simon Buckett
CFO of HealthTech Connex
Mr. Buckett brings with him over twelve years of finance and project management experience working for private and publicly listed companies in the UK, US, and Canada. Mr. Buckett began his career with KPMG in London and then in Vancouver as Senior Auditor, later joining Ernst & Young as an audit department Manager. Most recently he was Vice President of Finance at Wurldtech Security Technologies, Inc. His responsibilities have included internal control and governance policy, the implementation of Sarbanes-Oxley in a number of SEC registrants, and managing the reporting requirements of a range of private and public companies.
Follow Simon Buckett:
About HealthTech Connex: HealthTech Connex focuses on technology-based innovations for health improvements and outcomes.
Ann Fehr
CFO of Aequus Pharmaceuticals
Fehr is the Principal at Fehr & Associates, and has held a number of senior level positions including having served as CFO of Carrus Capital Corporation (formerly BioWest Therapeutic Inc.), Global Minerals Ltd., and other companies listed on the TSX. During the course of her management and consulting career, Ms. Fehr has led a number of companies through significant change and corporate milestones such as public listing applications, mergers and acquisitions, as well as strategic planning and execution. Ms. Fehr is also an active volunteer in the community. Since 2013, she has been Treasurer and a Director for the Boys and Girls Clubs of South Coast BC.
Follow Ann Fehr:
About Aequus Pharmaceuticals: Aequus Pharmaceuticals is a pharmaceutical company that focuses on therapeutic areas, including neurology, ophthalmology, and transplant.
Corbin Director
CFO of RxAnte
Prior to joining RxAnte, Mr. Director was a venture capitalist at Radius Ventures where he concentrated on executing development and growth stage investments in the healthcare information technology, healthcare services, and medical technology sectors. He was also previously an investment banker at B.C. Ziegler & Co. where he specialized in healthcare M&A and private placement transactions. Mr. Director earned a BA in Physical Science from Colgate University and an MBA from the Wharton School at the University of Pennsylvania.
Follow Corbin Director:
About RxAnte: RxAnte offers predictive analytics and targeted clinical programs that improve medication prescribing and adherence.
Bruce Colwill
CFO of InMed Pharmaceuticals
Bruce Colwill is the Chief Financial Officer at InMed Pharmaceuticals.
Follow Bruce Colwill:
About InMed Pharmaceuticals: InMed Pharmaceuticals is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates.
Bill Adams
Chief Financial Officer of NervGen Pharma
Follow Bill Adams:
About NervGen Pharma: NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and neurodegenerative diseases.
William Washecka
CFO of Prestwick Pharmaceuticals
William Washecka is the chief financial officer of [Prestwick Pharmaceuticals](https://www.crunchbase.com/organization/prestwick-pharmaceuticals-inc#/entity), a company that develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. He was previously a senior partner of Ernst & Young.
Follow William Washecka:
About Ernst & Young, Prestwick Pharmaceuticals: Prestwick Pharmaceuticals develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases.
